SUBSCRIBE
SUBSCRIBE

Georgia

a robotic assembly line with vials
Opinion
Invest in Domestic Manufacturing to Onshore America’s Biotech Supply Chain
As the U.S. moves away from reliance on Chinese CDMOs, Southern cities provide a model for how we can bolster domestic production capacity.
August 14, 2024
 · 
5 min read
 · 
Josh Carpenter
Pictured: Skyline of Atlanta
Business
Atlanta’s Biotech Scene Prepares for New Heights
The Atlanta area is receiving more physical real estate options to foster its burgeoning biotech industry.
May 1, 2024
 · 
6 min read
 · 
Tyler Patchen
PRESS RELEASES
Press Releases
UCB Receives U.S. FDA Approval for BIMZELX® (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate-to-Severe Hidradenitis Suppurativa
November 20, 2024
 · 
15 min read
Press Releases
Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimer’s Transgenic Mice
November 19, 2024
 · 
5 min read
Press Releases
Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study
November 19, 2024
 · 
6 min read
Press Releases
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
November 18, 2024
 · 
4 min read
Press Releases
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
November 15, 2024
 · 
8 min read
Press Releases
New BIMZELX® (bimekizumab-bkzx) Data at ACR Convergence 2024 Highlights UCB’s Efforts to Deliver Differentiated Care for Patients with Psoriatic Arthritis and Axial Spondyloarthritis
November 14, 2024
 · 
24 min read
Press Releases
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update
November 14, 2024
 · 
8 min read
Press Releases
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
November 13, 2024
 · 
9 min read
Press Releases
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
November 12, 2024
 · 
12 min read
Press Releases
Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference
November 12, 2024
 · 
1 min read
Press Releases
ON-Q* Elastomeric Infusion Pump and ambIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025
November 12, 2024
 · 
3 min read
Press Releases
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024
November 11, 2024
 · 
1 min read
Press Releases
Dogwood Therapeutics Announces Third Quarter 2024 Financial Results
November 8, 2024
 · 
8 min read
Press Releases
Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema
November 8, 2024
 · 
7 min read
Press Releases
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
November 7, 2024
 · 
4 min read
Press Releases
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
November 6, 2024
 · 
1 min read
Press Releases
Avanos Medical Launches New CORGRIP® SR
November 5, 2024
 · 
1 min read
Press Releases
Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors
November 5, 2024
 · 
5 min read
Press Releases
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
November 1, 2024
 · 
4 min read
Press Releases
Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024
November 1, 2024
 · 
1 min read
Load More